Eli Lilly Keeps Most Of Weight Loss Drug Copy Suit Alive

By Adam Lidgett · March 27, 2026, 7:59 PM EDT

A California federal judge has refused to throw out a lawsuit accusing a pair of telehealth companies of making copies of Eli Lilly's obesity and type 2 diabetes drugs but agreed...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

Eli Lilly and Company v. Aios, Inc.

Case Number

Court

California Northern

Nature of Suit

Other Statutory Actions

Date Filed

April 23, 2025

Recent Articles By Adam

March 24, 2026
Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP
March 24, 2026
ITC Says Hydrafacial Patent Infringed, But Won't Ban Imports
March 12, 2026
US Chamber Report Warns Of Risks To IP Protection
March 04, 2026
Care Management Co. Accused Of Swiping Software Platform
February 23, 2026
CBP Clears Redesigned Tourniquet Imports After IP Ban
February 09, 2026
Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.
February 09, 2026
High Court Asked To Take Up Malpractice Case Against Akin
February 06, 2026
PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test
February 02, 2026
PTAB Sinks Samsung Challenge To Ouraring Patent
January 22, 2026
AI Diagnostics Co.'s Patent Claims Don't Pass Alice Test